A New Label for Mifepristone.
From the Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston (M.F.G.).
Michael F
MF
Greene
From the Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston (M.F.G.).
Jeffrey M
JM
Drazen
D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D005260:Female; D033161:Government Regulation; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage; D011247:Pregnancy; D013219:State Government; D014481:United States; D014486:United States Food and Drug Administration
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone